Screener
Amneal Pharmaceuticals, Inc. AMRX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 44,361 | 38,832 |
| Operating lease right-of-use assets - related party | 13,723 | 15,216 |
| Financing lease right-of-use assets | 52,360 | 53,328 |
| Other assets | 80,669 | 57,805 |
| Total assets | $3,776,348 | $3,678,280 |
| Liabilities and Stockholders’ Equity (Deficiency) | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $721,208 | $761,316 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Amneal Pharmaceuticals, Inc.'s other non-current assets?
- Amneal Pharmaceuticals, Inc. (AMRX) reported other non-current assets of $80.67M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s other non-current assets changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s other non-current assets increased by 79.9% year-over-year, from $44.85M to $80.67M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s other non-current assets has grown at a 20.9% compound annual growth rate (CAGR), from $22.34M to $57.81M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Amneal Pharmaceuticals, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude